Literature DB >> 17879399

RNA interference-mediated gene silencing of vascular endothelial growth factor in colon cancer cells.

Tie-Jun Li1, Jian-Ning Song, Kai Kang, Shu-Sheng Tong, Zan-Lan Hu, Tong-Chuan He, Bing-Qiang Zhang, Cai-Quan Zhang.   

Abstract

AIM: To inhibit the expression of vascular endothelial growth factor (VEGF) in colon cancer cell line by RNA interference (RNAi).
METHODS: Followed the service of E-RNAi, we designed and constructed two kinds of shRNA expression vectors aiming at the VEGF gene, then transfected them into colon cancer HT29 cells by lipofectamine(TM) 2000. The level of VEGF mRNA was investigated by RT-PCR and Northern blotting. The protein expression of VEGF was observed by immunofluoresence staining and Western blotting.
RESULTS: We got two kinds of VEGF specific shRNA expression vectors which could efficiently inhibit the expression of VEGF in HT29 cells. RT-PCR, Northern blotting, immunofluoresence staining and Western blotting showed that inhibition rate for VEGF expression was up to 42%, 89%, 73% and 82%, respectively.
CONCLUSION: The expression of VEGF can be inhibited by RNA interference in HT29 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17879399      PMCID: PMC4171319          DOI: 10.3748/wjg.v13.i40.5312

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  RNAi and related mechanisms and their potential use for therapy.

Authors:  Reuven Agami
Journal:  Curr Opin Chem Biol       Date:  2002-12       Impact factor: 8.822

Review 2.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 3.  RNA interference--small RNAs effectively fight viral hepatitis.

Authors:  Amir Shlomai; Yosef Shaul
Journal:  Liver Int       Date:  2004-12       Impact factor: 5.828

4.  Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo.

Authors:  Francesca Wannenes; Silvia Anna Ciafré; Francesco Niola; Gaetano Frajese; Maria Giulia Farace
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

5.  VEGF upregulates Bcl-2 expression and is associated with decreased apoptosis in neuroblastoma cells.

Authors:  Elizabeth A Beierle; Louise F Strande; Mike K Chen
Journal:  J Pediatr Surg       Date:  2002-03       Impact factor: 2.545

6.  VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition.

Authors:  Sergio Dias; Sergey V Shmelkov; George Lam; Shahin Rafii
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

7.  Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells.

Authors:  Abby L Mulkeen; Teresa Silva; Peter S Yoo; John C Schmitz; Edward Uchio; Edward Chu; Charles Cha
Journal:  Arch Surg       Date:  2006-04

8.  Using double-stranded RNA to prevent in vitro and in vivo viral infections by recombinant baculovirus.

Authors:  Victor Julian Valdes; Alicia Sampieri; Jorge Sepulveda; Luis Vaca
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

9.  Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR.

Authors:  Jingping Du; Yanglin Pan; Yongquan Shi; Changcun Guo; Xiaohang Jin; Li Sun; Na Liu; Taidong Qiao; Daiming Fan
Journal:  Int J Cancer       Date:  2005-01-10       Impact factor: 7.396

10.  Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.

Authors:  Yang Fan; Xiao-Yan Xin; Bi-Liang Chen; Xiangdong Ma
Journal:  Pathology       Date:  2006-12       Impact factor: 5.306

View more
  2 in total

1.  siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.

Authors:  Bo-Young Oh; Ryung-Ah Lee; Kwang Ho Kim
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.

Authors:  Patrick Arbuthnot; Liam-Jed Thompson
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.